Sectors
PRQR
ProQR Therapeutics N.V.
1.85
27 x 1.85
46 x 1.86
bid
ask
-
0.03
1.49%
01:43 PM
timesize
| Ytd | -8.32% | |
| 1y | -18.78% |
1.80
day range
1.90
1.33
52 week range
3.10
| Open | 1.87 | Prev Close | 1.88 | Low | 1.80 | High | 1.90 | Mkt Cap | 197.98M |
| Vol | 548.80K | Avg Vol | 1.02M | EPS | -0.50 | P/E | -3.76 | Forward P/E | -5.68 |
| Beta | 0.04 | Short Ratio | 0.31 | Inst. Own | 24.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.63 | 200-d Avg | 1.87 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 2.03M | ||
| Revenues (USD) | 2.34M | ||
| Gross Profit | 2.03M | ||
| Operating Expenses | 15.68M | ||
| Research and Development Expense | 11.83M | ||
| Selling, General and Administrative Expense | 3.85M | ||
| Operating Income | -13.65M | ||
| Interest Expense | -212.00K | ||
| Net Income | -13.38M | ||
| Net Income Common Stock | -13.38M | ||
| Net Income Common Stock (USD) | -15.38M | ||
| Consolidated Income | -13.38M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -13.59M | ||
| Earning Before Interest & Taxes (USD) | -15.63M | ||
| Weighted Average Shares | 105.36M | ||
| Weighted Average Shares Diluted | 105.36M | ||
| Balance Sheet | |||
| Cash and Equivalents | 81.09M | ||
| Cash and Equivalents (USD) | 93.20M | ||
| Trade and Non-Trade Receivables | 4.40M | ||
| Current Assets | 86.98M | ||
| Property, Plant & Equipment Net | 12.05M | ||
| Total Assets | 99.03M | ||
| Debt Current | 6.66M | ||
| Total Debt | 15.73M | ||
| Current Liabilities | 35.06M | ||
| Debt Non-Current | 9.07M | ||
| Total Liabilities | 61.44M | ||
| Shareholders Equity | 37.60M | ||
| Shareholders Equity (USD) | 43.22M | ||
| Assets Non-Current | 12.05M | ||
| Total Debt (USD) | 18.08M | ||
| Deferred Revenue | 36.91M | ||
| Liabilities Non-Current | 26.38M | ||
| Trade and Non-Trade Payables | 189.00K | ||
| Tax Assets | 1.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 694.00K | ||
| Net Cash Flow from Financing | -304.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.61M | ||
| Capital Expenditure | -164.00K | ||
| Issuance (Repayment) of Debt Securities | -304.00K | ||
| Net Cash Flow from Investing | -164.00K | ||
| Net Cash Flow from Operations | -11.46M | ||
| Effect of Exchange Rate Changes on Cash | 288.00K | ||
| Share Based Compensation | 1.43M | ||